238 related articles for article (PubMed ID: 31240814)
21. Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells.
Vouri M; An Q; Birt M; Pilkington GJ; Hafizi S
Oncotarget; 2015 Jun; 6(18):16183-97. PubMed ID: 25980499
[TBL] [Abstract][Full Text] [Related]
22. Super-enhancer-associated TMEM44-AS1 aggravated glioma progression by forming a positive feedback loop with Myc.
Bian E; Chen X; Cheng L; Cheng M; Chen Z; Yue X; Zhang Z; Chen J; Sun L; Huang K; Huang C; Fang Z; Zhao B; Li J
J Exp Clin Cancer Res; 2021 Oct; 40(1):337. PubMed ID: 34696771
[TBL] [Abstract][Full Text] [Related]
23. Long noncoding FOXD2-AS1 is activated by CREB1 and promotes cell proliferation and metastasis in glioma by sponging miR-185 through targeting AKT1.
Dong H; Cao W; Xue J
Biochem Biophys Res Commun; 2019 Jan; 508(4):1074-1081. PubMed ID: 30553445
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding antisense RNA GAS6-AS1 supports gastric cancer progression via increasing GAS6 expression.
Zhang P; Dong Q; Zhu H; Li S; Shi L; Chen X
Gene; 2019 May; 696():1-9. PubMed ID: 30735718
[TBL] [Abstract][Full Text] [Related]
25. LncRNA LINC00689 promotes the growth, metastasis and glycolysis of glioma cells by targeting miR-338-3p/PKM2 axis.
Liu X; Zhu Q; Guo Y; Xiao Z; Hu L; Xu Q
Biomed Pharmacother; 2019 Sep; 117():109069. PubMed ID: 31181442
[TBL] [Abstract][Full Text] [Related]
26. LncRNA LINC00998 inhibits the malignant glioma phenotype via the CBX3-mediated c-Met/Akt/mTOR axis.
Cai H; Yu Y; Ni X; Li C; Hu Y; Wang J; Chen F; Xi S; Chen Z
Cell Death Dis; 2020 Dec; 11(12):1032. PubMed ID: 33268783
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNA H19 regulates HIF-1α/AXL signaling through inhibiting miR-20b-5p in endometrial cancer.
Zhu H; Jin YM; Lyu XM; Fan LM; Wu F
Cell Cycle; 2019 Oct; 18(19):2454-2464. PubMed ID: 31411527
[TBL] [Abstract][Full Text] [Related]
28. NF-κB-mediated miR-650 plays oncogenic roles and activates AKT/ERK/NF-κB pathways by targeting RERG in glioma cells.
Jin S; Li X; Dai Y; Li C; Wang D
Cell Oncol (Dordr); 2020 Dec; 43(6):1035-1048. PubMed ID: 32986146
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA PAR5 inhibits the proliferation and progression of glioma through interaction with EZH2.
Wang XP; Shan C; Deng XL; Li LY; Ma W
Oncol Rep; 2017 Nov; 38(5):3177-3186. PubMed ID: 29048683
[TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNA SNGH7 Is activated by SP1 and exerts oncogenic properties by interacting with EZH2 in ovarian cancer.
Bai Z; Wu Y; Bai S; Yan Y; Kang H; Ma W; Zhang J; Gao Y; Hui B; Ma H; Li R; Zhang X; Ren J
J Cell Mol Med; 2020 Jul; 24(13):7479-7489. PubMed ID: 32420685
[TBL] [Abstract][Full Text] [Related]
31. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
[TBL] [Abstract][Full Text] [Related]
32. Inactivation of GSK3β and activation of NF-κB pathway via Axl represents an important mediator of tumorigenesis in esophageal squamous cell carcinoma.
Paccez JD; Duncan K; Vava A; Correa RG; Libermann TA; Parker MI; Zerbini LF
Mol Biol Cell; 2015 Mar; 26(5):821-31. PubMed ID: 25568334
[TBL] [Abstract][Full Text] [Related]
33. Long noncoding RNA LINC01426 promotes glioma progression through PI3K/AKT signaling pathway and serves as a prognostic biomarker.
Wang SJ; Wang H; Zhao CD; Li R
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6358-6368. PubMed ID: 30338804
[TBL] [Abstract][Full Text] [Related]
34. LncRNA HOTAIR regulates HIF-1α/AXL signaling through inhibition of miR-217 in renal cell carcinoma.
Hong Q; Li O; Zheng W; Xiao WZ; Zhang L; Wu D; Cai GY; He JC; Chen XM
Cell Death Dis; 2017 May; 8(5):e2772. PubMed ID: 28492542
[TBL] [Abstract][Full Text] [Related]
35. Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival.
Vajkoczy P; Knyazev P; Kunkel A; Capelle HH; Behrndt S; von Tengg-Kobligk H; Kiessling F; Eichelsbacher U; Essig M; Read TA; Erber R; Ullrich A
Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5799-804. PubMed ID: 16585512
[TBL] [Abstract][Full Text] [Related]
36. p53-targeted lncRNA ST7-AS1 acts as a tumour suppressor by interacting with PTBP1 to suppress the Wnt/β-catenin signalling pathway in glioma.
Sheng J; He X; Yu W; Chen Y; Long Y; Wang K; Zhu S; Liu Q
Cancer Lett; 2021 Apr; 503():54-68. PubMed ID: 33476649
[TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
[TBL] [Abstract][Full Text] [Related]
38. Axl Is a Potential Cancer Prognostic Marker for the Migration and Invasion of Nasopharyngeal Carcinoma.
Jiang C; Zhou L; Wang H; Zhang Q; Xu Y
Adv Clin Exp Med; 2016; 25(3):531-7. PubMed ID: 27629742
[TBL] [Abstract][Full Text] [Related]
39. The transcription factor USF1 promotes glioma cell invasion and migration by activating lncRNA HAS2-AS1.
Wang J; Gu J; You A; Li J; Zhang Y; Rao G; Ge X; Zhang K; Li J; Liu X; Wang Q; Lin T; Cheng L; Zhu M; Wu X; Wang D
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32776110
[TBL] [Abstract][Full Text] [Related]
40. Long non‑coding RNA LINC00473/miR‑195‑5p promotes glioma progression via YAP1‑TEAD1‑Hippo signaling.
Wang X; Li XD; Fu Z; Zhou Y; Huang X; Jiang X
Int J Oncol; 2020 Feb; 56(2):508-521. PubMed ID: 31894297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
